Global Markets for Membrane Technology for Pharmaceuticals

REPORT HIGHLIGHTS

• The global market for membrane technology reached $3.8 billion in 2010, nearly $4.6 billion in 2011, and is forecast to reach $7.3 billion in 2016 after increasing at a compound annual growth rate (CAGR) of 9.9%.
• The pharmaceutical market was valued at nearly $1.7 billion in 2010 and $2  billion in 2011. It is expected to grow to $3.2 billion in 2016, a CAGR of 9.9% between 2011 and 2016.
• The biopharmaceutical market reached nearly $2 billion in 2010 and $2.4 billion in 2011. The market is expected to reach nearly $3.9 billion by 2016, a CAGR of 10.1%.

REPORT SCOPE

INTRODUCTION

REASONS FOR DOING THE STUDY

Membrane technology is used in all phases of the pharmaceutical development processes, from laboratory research to large-scale pharmaceutical manufacturing. Applications include lab-scale DNA and protein separation and analysis, sample preparation, drug screening, cell culturing and examination, laboratory and process water purification, virus removal, and bench-, pilot-, and production-scale drug manufacturing.

Substantial changes in the pharmaceutical and biopharmaceutical industries have made membrane separations processes an important part of the production of drugs. Membrane separation processes help ensure safety and efficacy of drugs by eliminating contaminants from the laboratory through large-scale production.

This study is an update of a previous report from 2005; it combines bio-pharmaceutical, life science research, and pharmaceutical membrane separation technologies.

STUDY GOALS AND OBJECTIVES

This report provides an in-depth analysis of the market for membrane technology in pharmaceuticals, life sciences, and biopharmaceutical applications. Areas in the report include laboratory analysis (e.g., gene and protein analysis, drug candidate screening, laboratory separations and water treatment), biopharmaceutical development (e.g., cell culturing, protein purification, virus removal) and pharmaceutical manufacturing.

Technical and market drivers are considered in evaluating the current value of the technologies and in projecting growth and trends over the next five years. Conclusions are illustrated with statistical information on markets, applications, industry structure and dynamics, and technological developments.

In addition to coverage of membrane technology by type, the report will segment the market by region, including the Americas (U.S., Canada, Latin America, South America); Europe, Middle East, Russia, and Africa (EMRA); and Asia (Japan, Australia/New Zealand, India, China, other Asia-Pacific areas).

SCOPE AND FORMAT

The study is intended for individuals requiring an in-depth analysis of the life science, pharmaceutical, and biopharmaceutical membrane separation technology industries. It traces significant developments and forecasts important trends, quantifies the various market sectors, and highlights companies active in those areas.

The report will not cover membranes used in the healthcare or medical diagnostics fields, or membranes used in air and gas venting on medical devices.

INTENDED AUDIENCE

This study will be of interest to membrane device manufacturers, membrane material manufacturers, and venture capitalists and financial institutions involved in the healthcare industry.

METHODOLOGIES AND INFORMATION SOURCES

Both primary and secondary research methodologies were used in preparing this study. A comprehensive literature, patent, and Internet search was conducted. Additionally, business, scientific, and industry journals; government reports; annual reports; conference literature; and Securities and Exchange Commission (SEC) reports were consulted. Industry experts were consulted as necessary.

Growth rates were calculated based on existing and proposed device and equipment sales during the forecast period. Membrane consumables were also taken into account.

Values are given in U.S. dollars; forecasts are made in constant U.S. dollars, and growth rates are compounded. Calculations do not include design nor installation costs or validation expenses.

ANALYST CREDENTIALS

Peggy S Lehr is the BCC Research analyst of this report. Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder, and an MS in Communication from the University of Denver. Ms. Lehr has worked in the publishing industry for both for-profit and not-for-profit organizations, and she has completed more than 20 reports for BCC.

BCC ON-LINE SERVICES

BCC Research offers an online information retrieval service. Its home page, located at www.bccresearch.com, enables readers to:

• Examine the complete BCC Research catalog of market research reports and place direct orders.
• Subscribe to any of BCC Research’s many industry newsletters.
• Read announcements of recently published reports and newly launched newsletters.
• Register for its well-known conferences.
• Request additional information on any BCC research product.
• Take advantage of special offers.

DISCLAIMER

The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal or accounting advice, nor should it serve as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is of a speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or from its use.

RELATED REPORTS

• FCB035C − Materials for Proton Exchange Membranes and Membrane Electrode Assemblies for PEM Fuel Cells
• BIO011E − Separations Systems for Commercial Biotechnology
• MST044C − Ultrafiltration Membranes: Technologies and the U.S. Market
• MST043E − Medical Membrane Devices: Markets and Technologies